ABSTRACT. Fatty acid binding protein 4 (FABP4) is an important adipocyte gene, with roles in fatty acid transport and fat deposition in animals as well as human metabolic syndrome. However, little is known about the functional regulation of FABP4 at the cellular level in bovine. We designed and selected an effective shRNA (small hairpin RNA) against bovine FABP4, constructed a corresponding adenovirus (AD-FABP4), and then detected its influence on mRNA expression of four differentiation-related genes (PPARᵧ, CEBPA, CEBPB, and SREBF1) and three lipid metabolism-related genes (ADIPOQ, LEP and LEPR) of adipocytes. The FABP4 mRNA content, derived from bovine adipocytes, decreased by 41% (P < 0.01) after 24 h and 66% (P < 0.01)
INTRODUCTION
Health conscience consumers are likely to purchase meat products with healthier/ lesser types/amounts of fat (Dodson et al., 2010a) , thus driving research in meat animal adipogenesis (Hausman et al., 2009 ) and lipid metabolism (Dodson et al., 2010a) . Interest in using cattle for research studies has increased during the past few years for other reasons. Sufficient (isolatable) adipose tissue is present in all adipose depots of cattle for cell isolation and comparative evaluation (Dodson et al., 2010b ) and a broadening database of research tools is rapidly being developed for bovine adipose research models. Furthermore, previous studies have indicated that the physiology of adipocytes derived from cattle may be different from other well-understood adipocyte models (such as 3T3-L1) (Fernyhough et al., 2007; Taniguchi et al., 2008a,b; Dodson et al., 2010a,c; Poulos et al., 2010) . Bovine adipocytes with potential dominance are the cell model of studying adipogenesis and lipid metabolism for improving animal production and serving human health. Thus, it is important to improve our understanding of adipocyte physiology and functions of key adipokines in cattle.
FABP4 (fatty acid binding protein 4), also known as A-FABP (adipocyte fatty acid binding protein), ALBP (adipocyte lipid binding protein), or ap2 (adipocyte protein-2), is a member of the tissue-specific FABP family, which possesses high affinity for fatty acids and is involved in the transport of long-chain fatty acids within the adipocyte (Ockner et al., 1972) . Studies suggest that FABP4 is directly related to fatness traits and may be a potential marker for beef tenderness and intramuscular fat content (Michal et al., 2006; Jurie et al., 2007; Hoashi et al., 2008; Barendse et al., 2009; Lee et al., 2010; Mannen, 2011; Narukami et al., 2011; Zhao et al., 2012) . However, the FABP4 gene function at the cellular level of cattle remains unclear.
RNA interference is used in detecting gene function and regulation mechanisms by reducing/partially silencing (knocking down) the mRNA produced from gene expression (Fire et al., 1998; Tuschl, 2001 ) via posttranscriptional gene silencing induced by small RNA fragments (Fire et al., 1998) . The specific mRNA of any targeted gene may be elicited by either transfection of double-strand silencing RNA (siRNA), small hairpin RNA (shRNA), or stimulating cells to express siRNA by manipulating its genome via vectors. Compared to double-strand RNA injection or transfection of eukaryotic vectors, an adenovirus vector, which could be used in gene therapy, has manifested predominance for primary cell lines, with high transduction efficiency and long-term knockout of gene transcripts. Therefore, an adenovirus vector (pENTR/CMV-GFP/U6 and pAD/BLOCK-IT TM -DEST RNA interference system) carrying four specific shRNA (targeted part of the mRNA derived from bovine FABP4) was selected and used in this study. By using this system, we aimed to select an effective shRNA targeting bovine FABP4 and define the gene function of FABP4 and its involvement in bovine adipocyte gene expression, differentiation and lipid metabolism. The hypothesis tested was that FABP4 manipulation may be used to affect changes in bovine adipocyte physiology.
MATERIAL AND METHODS

Adenovirus vector, shRNA design and construction
Adenovirus vector, pENTR/CMV-GFP/U6 and the pAD/BLOCK-IT TM -DEST system, containing a U6 promoter and green fluorescent protein (GFP) sequences, was used in this experiment. Four pairs (two complementary single-stranded DNA oligonucleotides for each pair) of shRNA against FABP4 mRNA sequences (GenBank accession No. NM_174314.2) were designed synthetically using several online tool designers (Promega, Invitrogen and Whitehead Institute), with the restriction enzyme sites BamHI and XhoI and hairpin construction sequences 5'-GAGTACTG-3' (with restriction enzyme site ScaI), and then synthesized by Invitrogen, Inc. The shRNA start positions and target sequences in FABP4 mRNA were designed as follows: shRNA 202 (5'-GGTGTGGTCACCATTAAAT-3'), shRNA 207 (5'-GGTCACCATTAAATCAGAA-3'), shRNA 261 (5'-GGGCCAGGAATTTGATGAA-3'), and shRNA 304 (5'-GAGCATCGTAAACTTAGAT-3'). The control shRNA (shNC, sequences: 5'-TTCTCCGAACGTGTCACGT-3') without interference potential was synthesized as well. Each annealed double-stranded fragment of shRNA was first cloned into linearized pENTR/ CMV-GFP/U6 and subjected to an initial selection of effective shRNA against the FABP4 gene.
Initial selection of effective shRNA and adenovirus preparation FABP4 coding sequences were cloned and inserted into a pDsRed1-C1 vector. The primer sequences for FABP4 were designed as follows: sense -5'-CCGCTCGAGAAATGTGT GATGCATTTGTAGG-3', antisense -5'-CGGGATCCTGCTCTCTCATAAACTCTGGT-3' (product size of 414 bp, with restriction sites XhoI and BamHI), using the Primer Premier 5.0 software. To get the most efficient shRNA, the purified pENTR/CMV-GFP/U6/shRNA-FABP4 and pDsRed1-C1-FABP4 were co-transfected into HEK 293A cells using Lipofectamine TM 2000 (Invitrogen, Inc.). Co-transfected pENTR/CMV-GFP/U6/shRNA-NC and pDsRed1-C1-FABP4 HEK 293A cells were the control groups. Moreover, pENTR/CMV-GFP/U6/shRNA-NC and pDsRed1-C1-FABP4 were transfected separately as another group to monitor transfection efficiency. By visualization with an Olympus inverted research micro-scope, the pENTR/CMV-GFP/U6/shRNA-FABP4 and pDsRed1-C1-FABP4 plasmids could be observed by GFP and red fluorescent protein (RFP), respectively. As FABP4 and RFP were expressed as a fusion by pDsRed1-C1-FABP4, the efficiency of shRNA targeting FABP4 was detected by the red fluorescent diminish-degree on the third day after co-transfection. The GFP level was used in monitoring the transfection efficiency among groups. This selection was repeated three times with three duplicates each time, and the one with the highest effective shRNA was selected. The selective shRNA was then combined with pAD/BLOCK-IT TM -DEST using Gateway ® LR Clonase TM II Enzyme Mix (Invitrogen). By Lipofectamine TM 2000 (Invitrogen, Inc.), the linearized recombinant plasmid was transfected into HEK 293A cells. AD-FABP4 (adenovirus shRNA against FABP4) was then packaged and amplified until the virus achieved sufficient infection ability. AD-NC, which expressed the negative control (NC) shRNA, was prepared in parallel. Preparation of the adenovirus was in accordance with manufacturer instructions.
Animal/tissue samples
Perirenal fat was obtained from three newborn Chinese Holstein calves, taken to the cell culture laboratory and immediately soaked in warm PBS containing 100 IU/mL penicillin-100 μg/mL streptomycin (pen-strep). The samples from the three calves were handled separately from collection to the treatment detection process. The animal protocol was approved by the Experimental Animal Care and Use Committee of Northwest A&F University.
Cell isolation, cell culture and viral infection
The stromal vascular cells (SV cells; preadipocyte fraction) were isolated following the method described by Sun et al. (2009) , with minor modifications. Under sterile conditions, adipose tissues were rinsed with warm PBS and cut into small sections. Then, the samples were digested with an equal volume of enzyme solution (DMEM/F12 + 20 g/L BSA + 2 g/L type I collagenase) for 60 min at 37°C in a shaking water bath. DMEM/F12 containing 10% FBS was then added to stop the digestion. The solution was passed through 200-μm nylon filters and centrifuged at 800 g for 10 min to collect cells. The mixed suspension solution was decanted to remove mature adipocytes and enzyme. The bottom pellet was washed three times and re-suspended in DMEM/F12 containing 10% FBS, pen-strep and plated at a density of 5 x 10 4 cells/cm 2 . The isolated cells were subsequently cultured at 37°C in a humidified 5% CO 2 atmosphere. After 24 h, the plates were washed with PBS to remove unattached cells. The medium was changed every 2 days. When the cells reached confluence (day 0), they were separated into three groups: AD-FABP4-treated group, AD-NC-treated group and normal control group. The treated cells were exposed to differentiation medium (DMEM/F12 containing 10% FBS, pen-strep, 100 ng/mL dexamethasone, 10 µg/mL insulin, 10 µg/mL transferrin) plus infectious AD-FABP4 or AD-NC adenovirus, respectively. The normal control cells were treated only with the differentiation medium. The HEK 293A cell line was cultured in high glucose DMEM plus 10% FBS. All the cells were incubated in a humidified atmosphere of 37°C and 5% CO 2 .
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Real-time PCR
Total RNA was extracted with the E.Z.N.A TM total RNA kit I (Invitrogen) at 24 and 72 h after viral infection. The RNA for assay was treated with DNase I for 30 min to remove the genomic DNA before being dissolved in RNase-free water. The A 260 /A 280 ratio of purified RNA was between 1.6 and 1.8. Samples were then processed for cDNA synthesis using a reverse transcription kit (Fermentas). Gene expression of four differentiation-related genes (PPARᵧ, CEBPA, CEBPB, and SREBF1) and three lipid metabolism-related genes (ADIPOQ, LEP and LEPR) was detected in this experiment. The primer sequences are shown in Table 1 . GAPDH and ACTB were used as dual endogenous controls. Real-time PCR was carried out in a 20-μL reaction mixture containing 50 ng cDNA, 0.4 μM each primer, 10 μL SYBR ® Premix Ex Taq TM II (TaKaRa Biotechnology, Japan), 0.4 μL ROX Reference Dye II (TaKaRa Biotechnology). PCR conditions were as follows: pre-denaturation step at 95°C for 30 s, 40 cycles of the PCR steps, namely denaturation at 95°C for 5 s and extension at 60°C for 34 s, followed by a dissociation cycle of 95°C for 15 s, 60°C for 1 min and 95°C for 15 s to obtain the melting curve.
All the quantitative RT-PCRs were performed in triplicate on an ABI 7500 machine (Applied Biosystems), based on a standard curve method. All data analysis was performed as recommended by the manufacturer. 
Statistical analysis
Statistical analysis was performed using SPSS 13.0. All results are reported as means ± standard deviation (SD). Statistical differences between the AD-FABP4 treatment groups and AD-NC control groups were compared by one-way analysis of variance (ANOVA) followed by the post hoc Duncan test. P less than 0.05 and P less than 0.01 were considered to be statistically significant or very significant, respectively.
shRNA interference of FABP4 in bovine adipocytes
RESULTS
Initial selection of effective shRNA and adenovirus preparation
Construction of pENTR/CMV-GFP/U6-shRNA and pDsRed1-C1-FABP4 was confirmed by ScaI and BamHI plus XhoI enzyme digestion, respectively (Figure 1) , followed by sequencing. FABP4 and pDsRed1-C1 vector-derived RFP were co-expressed as a fusion protein (FABP4-RFP) in HEK 293A cells by pDsRed1-C1-FABP4. In co-transfected pENTR/CMV-GFP/U6-shRNA and pDsRed1-C1-FABP4 cell plates, effective shRNA (targeted FABP4) reduced the red fluorescence by partially silencing the FABP4-RFP mRNA. According to the diminished degree of red fluorescence, the most effective shRNA 261 was observed (Figure 2 ). Moreover, green fluorescence expressed by the single pENTR/ CMV-GFP/U6-transfected group was similar between groups, indicating that there was no difference in transfection efficiency. pENTR/CMV-GFP/U6-shRNA 261 and pENTR/CMV-GFP/U6-shRNA-NC were then recombined with pAD/BLOCK-IT TM -DEST, respectively. After the confirmation of PacI enzyme digestion ( Figure 3 ) and sequencing, adenovirus AD-FABP4 (shRNA adenovirus against FABP4 and derived from shRNA 261) and AD-NC (control shRNA adenovirus and derived from shRNA-NC) were produced by the positive plasmids. Infectious adenovirus was then used to infect the bovine-derived preadipocytes. GFP expressions after 72 h infection of AD-FABP4 to preadipocytes are shown in Figure 4 . 
Interferential efficiency of AD-FABP4 and influence on mRNA expression of other related genes
In this experiment, effective AD-FABP4 was designed and constructed successfully; it decreased FABP4 mRNA by 41 (P < 0.01) and 66% (P < 0.01) at 24 and 72 h, respectively. After 24 h of AD-FABP4 infection, with 41% interference efficiency of FABP4, ADIPOQ and LEP resulted in a 41 (P < 0.05) and 73% (P < 0.01) decrease, respectively, compared with the AD-NC treatment groups. However, the expression of differentiation-related genes (PPARᵧ, CEBPA, CEBPB, and SREBF1) was not influenced significantly by down-regulation of the FABP4 gene at this time (P = 0.54, 0.78, 0.89, and 0.94, respectively) ( Figure 5 ). At 72 h after AD-FABP4 infection, when FABP4 decreased 66%, the expression of ADIPOQ and LEP genes decreased by 57% (P < 0.01) and 80% (P < 0.01), respectively. Meanwhile, LEPR gene expression increased 6.75-fold (P < 0.01) (Figure 6 ). The results suggest that FABP4 may play a role in regulating lipid metabolism-related genes (such as ADIPOQ, LEP and LEPR), without affecting the ability of preadipocytes to differentiate to adipocytes. 
DISCUSSION
Studies have focused on the relationship between FABP4 and economic traits in cattle. Jurie et al. (2007) showed that FABP4 protein content in muscle was correlated with triacylglycerol content. Hoashi et al. (2008) identified that FABP4 was associated with palmitoleic acid composition in intramuscular fat of Japanese Black cattle. Similar findings were published by Mannen (2011) and Narukami et al. (2011) in Holstein steers. Moreover, other research also suggested that bovine FABP4 was associated with beef tenderness (Zhao et al., 2012) , marbling (Michal et al., 2006; Barendse et al., 2009; Lee et al., 2010) , subcutaneous fat depth (Michal et al., 2006) , and carcass weight (Lee et al., 2010) , indicating the importance of FABP4 on animal carcass composition. Thus, the function of bovine FABP4 at the cellular level needs to be determined.
shRNA interference was used in this study to detect the gene function of bovine FABP4. DNA plasmid and virus vectors are the main shRNA carriers, showing priority to unstable non-vector system. However, usage of DNA plasmid vectors results in low transfection efficiency in primary cultured cells. Owing to high efficiency and safety of manipulating the adenovirus system, in this experiment, adenovirus-mediated shRNA was selected to decrease FABP4 gene expression of bovine preadipocytes. To get effective shRNA, four pairs of shRNA were designed and compared by first co-transfecting pENTR/CMV-GFP/U6-shRNA and pDsRed1-C1-FABP4 239A cells. Through this system, the best shRNA could be picked by the fluorescence efficiently without extensive time and/or materials. Here, we showed that shRNA 261, with the lowest red fluorescence after co-transfection, had the highest interferential efficiency and could be used for subsequent adenovirus recombination and packaging. In HEK 293A cells, red fluorescent diminish degree of the shRNA 261 group by more than 80% compared with the shNC group after 3 days of transfection. However, real-time PCR showed that final adenovirus AD-FABP4 had 66% interferential efficiency with primary bovine preadipocytes. The reason may be associated with the specific differences, different cell types and the different contents of FABP4 in adipocytes.
In addition to the gene coding region, siRNA could target UTR as well, especially the 3'-UTR in animals. However, these regions usually contain binding sequences for regulatory proteins, which may affect siRNA interference. Therefore, in this experiment, just the coding region was selected to test shRNA, although there are some reports of silencing the expression of several genes by targeting the UTR (Yu et al., 2002) . Recently, Bork et al. (2011) suggested that 3'-UTR of FABP4 may be a direct target of human miR-369-5p. Considering that the FABP4 3'-UTR of human and bovine has 78% identity, it will be interesting to detect the bovine miR-369-5p functions and further compare the interferential efficiency of the miR-369-5p and shRNA 261 detected in this experiment. Peroxisome proliferator-activated receptor gamma (PPARᵧ) was expressed in the early phase of bovine preadipocyte differentiation and is considered a critical transcription factor (Hirai et al., 2007a,b) . We hypothesized that FABP4, as a downstream gene of the PPARᵧ signaling pathway, could influence adipocyte differentiation and conformation via changing the fatty acids and acting through feedback regulation. Moreover, as adipogenesis is closely related to meat quality and fat deposition (Hausman et al., 2009; Dodson et al., 2010a, c) , studies in this area are important for animal production. Therefore, several differentiationrelated genes (PPARᵧ, CEBPA, CEBPB, and SREBF1) were detected after 24 h of AD-FABP interference, when these genes play key roles in regulating adipocyte differentiation. However, our study showed that, with a 41% decrease in FABP4 mRNA expression after 24 h of AD-FABP4 treatment, the expression of these genes was not affected, indicating that FABP4 may not influence the differentiation of preadipocytes to fat cells. This result is consistent with FABP4 knockout mice reported by Hotamisligi et al. (1996) , who first showed that mice with decreased FABP4 level seemed to develop adipocytes normally.
Adipose tissue is not only an energy depot but also an endocrine organ, secreting a variety of bioactive substances (called adipokines), which are actively involved in insulin sensitivity, and glucose and lipid metabolism. ADIPOQ (adiponectin) has been identified as a susceptibility locus for the metabolic syndrome, type 2 diabetes mellitus and cardiovascular disease (Vionnet et al., 2000; Francke et al., 2001) . LEP (leptin) and LEPR (leptin receptor) can have a profound impact on body weight, insulin resistance and other metabolic disease parameters (Enns et al., 2011 ). An additional study showed that variations in ADIPOQ, LEP and LEPR (adipokines) are associated with risk for obesity-related metabolic disease (Francke et al., 2001) , which have a similar function as FABP4. Thus, in this study, ADIPOQ, LEP and LEPR, which are associated with lipid metabolism (Vionnet et al., 2000; Witthuhn and Bernlohr, 2001; Francke et al., 2001; Enns et al., 2011) , were selected to determine the relationship with FABP4. In our study, by partially silencing bovine FABP4, ADIPOQ and LEP were found to decrease by 41 (P < 0.05) and 73% (P < 0.01) following a 24-h interference period. A 72-h treatment was then performed to detect their relationship. The results showed that with a 66% decrease in FABP4 mRNA content, all three of these lipid metabolism-related genes were extensively affected (P < 0.01), with a 57 and 80% decrease in ADIPOQ and LEP gene expression, respectively, and a 6.75-fold increase in LEPR mRNA expression. These results suggest that FABP4 may play a vital role in regulating lipid metabolism-related genes in the complicated gene network of adipocytes.
In conclusion, we first designed and selected effective shRNA targeting bovine FABP4, which decreased FABP4 mRNA expression by 66%, providing a guide for others to directly assess bovine FABP4 gene function studies. Furthermore, a preliminary test of FABP4 function was performed by detecting the relationship with differentiation-related genes and lipid metabolism-related genes. The results showed that lower FABP4 levels did not affect the differentiation-related genes (PPARᵧ, CEBPA, CEBPB, and SREBF1). Yet, we first discovered that ADIPOQ, LEP and LEPR genes were associated with FABP4 directly, and that lower FABP4 levels decreased ADIPOQ and LEP mRNA expression, while increasing LEPR gene expression, in bovine adipocytes. Collectively, FABP4 may play a role in regulating lipid metabolism-related genes (such as ADIPOQ, LEP and LEPR), without affecting the differentiation ability of preadipocytes. As FABP4 has been indicated as a biomarker for high quality of beef (Michal et al., 2006; Jurie et al., 2007; Hoashi et al., 2008; Barendse et al., 2009; Lee et al., 2010; Mannen, 2011; Narukami et al., 2011; Zhao et al., 2012) or human disease (Hotamisligil et al., 1996; Tuncman et al., 2006; Xu et al., 2006; Furuhashi et al., 2007) in previous studies, our research will provide a basis for further studies of bovine FABP4 functions and the involvement of FABP4 in gene signaling pathways.
